PPT-Cannabinoid

Author : karlyn-bohler | Published Date : 2017-04-27

Therapeutics Eloise Theisen RN MSN AGPCNPBC Green Health Consultants Overview Demographics Special considerations in geriatrics Clinical implications Case studies

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Cannabinoid" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Cannabinoid: Transcript


Therapeutics Eloise Theisen RN MSN AGPCNPBC Green Health Consultants Overview Demographics Special considerations in geriatrics Clinical implications Case studies Misconceptions Barriers. An Introduction. Spice, Spice Gold etc.. Definition: . Herbal Smoking Blends: Usually smoked for Marijuana-like effects believed to be caused by a mixture of synthetic cannabinoid drugs. Several different Brands of Herbal Smoke have been marketed and shown to contain different proportions of the synthetic cannabinoid, active ingredients, and reportedly produce subtly different effects. . 1:29-31. And God said, "Behold, I have given you every plant yielding seed that is on the face of all the earth, and every tree with seed in its fruit…it was very good!. A Short Excursus on Marijuana-Is it just “very good?”. Presentation to. University of Maryland Medical School. Quarterly Meeting. October 8, 2015. by. Deborah . Miran. Commissioner. Maryland Medical Cannabis Commission. Medical Cannabis – An Update. Milestones of the Twentieth Century . This program will include a discussion of investigational agents not approved by the FDA for use in the US, and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.. Christopher Campbell. PGY2 Pediatric Pharmacy Resident. Augusta University Medical Center . University of Georgia College of Pharmacy. Disclosure. I do not have (nor does any immediate family member have) actual or potential conflict of interest, within the last twelve . in . the. . Brain. Median Forebrain Bundle (MFB) . is the “reward center”. C. ontains . nerve cells . that contain . dopamine. , a pleasure-causing neurotransmitter. . . When stimulated by drugs of abuse (cocaine, meth, nicotine, . :IN. :IMLFF. @. This presentation does not constitute an offering of securities and the information contained herein is subject to the information contained in the Company’s continuous disclosure documents on SEDAR at www.sedar.com.. National Landscape of Marijuana Laws Source: National Conference of State Legislatures (2017), http://www.ncsl.org/research/health/statemedicalmarijuanalaws.aspxNote: Not all states’ laws are cur A new clinical condition With increasing rates of cannabis use, a new clinical condition known as cannabinoid hyperemesis 2] The population most a�ected by this disorder tly di� ntrol of Cannabinoid Receptor 2 – Mediated Ca 2+ R e lease Enabled By Synthesis of Photoswitchable Probes Roman C. Sarott, † Alexander E. G. Viray, ‡ Patrick Pfaff , † Anastasiia Sadybe Dr Uwe Grether Ligands and ReceptorsReceptors are important protein structures that allow cells to interact with the world around them (if they are on the cell surface) or help to control the activiti Neurotransmitters. Action Potentials Target . N. eurotransmitter Release. Neurotransmitters. Found in CNS and PNS. Over 100 in the body. Can be excitatory or inhibitory. Once released neurotransmitters will be decomposed by enzymes or up-taken by transporters in the pre-synaptic membrane. September 2016. What is Cannabis. Flowering plant that includes three subspecies; sativa, . indica. , . ruderalis. Chemical composition of cannabis is complex. 2 chemicals are responsible for the majority of of pharmacological effect, 9-delta-tetrahydrocannbinol (THC) and cannabidiol (CBD). Presented by Seddon R. Savage MD, MS. Survey Goals. Learn current and anticipated engagement by NH clinicians in use of herbal marijuana for therapeutic purposes. Assess clinician understanding of marijuana effects and side effects.

Download Document

Here is the link to download the presentation.
"Cannabinoid"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents